China Medical & HealthCare Group Limited provided earning guidance for the year ended 31 December 2020. The board of directors of the Company wishes to inform the shareholders of the Company and potential investors that based on its preliminary review on the relevant unaudited consolidated management accounts of the Group for the eleven months ended 30 November 2020 and information currently available, the Group is expected to record a loss attributable to shareholders of the Company for the year ended 31 December 2020 in the range of approximately HKD 30 million to HKD 60 million (subject to any further impairment, adjustment related to loan receivable or other adjustments) as compared with a net profit of approximately HKD 2.2 million for the corresponding period in 2019 (eighteen months). This was mainly due to (i) the decrease in revenue from the operations of the Healthcare Division and the Eldercare Division as affected by the negative impacts from the COVID-19 pandemic; (ii) no interest income being received from its money lending business; (iii) a loss in fair value of investments held for trading compared with a gain recorded in corresponding period in 2019 (eighteen months); and (iv) impairment loss recognized on financial assets.